Unitaid

20/02/2026

The 100 Days Mission 5th Implementation Report by the International Pandemic Preparedness Secretariat warns that global pandemic preparedness is slipping, with major gaps in diagnostics, therapeutics and the systems needed to deliver them quickly and equitably. Declining investment and fragile pipelines mean the 100-day target remains out of reach in many areas, even as outbreaks continue to expose weaknesses in early detection, coordination and access. The report makes clear that 2026 is a pivotal year to translate ambition into operational readiness.

Unitaid’s work in pandemic prevention and preparedness directly addresses these gaps. We are expanding access to multi-disease diagnostics that link testing to treatment through existing services, supporting late-stage development and market entry of next-generation and decentralized molecular tools, and accelerating access to multiplex platforms with partners including PATH, the Clinton Health Access Initiative and the Aurum Institute. Through strengthened collaboration with Africa CDC, Unitaid is also helping build regional regulatory, clinical research and manufacturing capacity, ensuring faster, fairer access to critical health tools before and during future outbreaks.

Find out more: https://ippsecretariat.org/news/pandemic-preparedness-slipping-just-as-global-risks-grow-new-100-days-mission-report-warns/

20/02/2026

Health supply chains — the invisible lifelines behind the delivery of essential medicines, diagnostics, and care — are highly vulnerable to rising temperatures, extreme weather, and environmental degradation. When heatwaves spoil medicines, floods block deliveries, or emissions

20/02/2026

Twenty years, 100+ health products introduced, and a 46 to 1 return on investment. That is Unitaid’s track record in turning promising health innovations into affordable, widely available tools. From HIV and TB treatments to diagnostics and preventive technologies, our work has shown that when access is planned early, innovation can deliver impact at scale rather than deepen inequities.

In his latest op-ed, Dr. Philippe Duneton argues that scaling this approach is not optional, it is fundamental to resilient, country-led global health systems. As global health financing contracts and reform accelerates, we must ensure that equitable access to innovation is treated as a core function of the system, not an afterthought. Connecting discovery to delivery is how we protect health budgets, strengthen sustainability, and ensure breakthroughs reach the people who need them most.

Read more in : https://www.thinkglobalhealth.org/article/the-global-health-reform-debates-dangerous-blindspot

20/02/2026

A United Kingdom Government review has reaffirmed Unitaid’s role as a critical enabler, amplifier and accelerator of global health investments. For the second year in a row, the Foreign, Commonwealth & Development Office awarded Unitaid an A+ rating, recognizing sustained strong performance and impact at scale. The review highlights how Unitaid bridges the gap between innovation and country health programmes, accelerating access to lifesaving products, shaping markets to lower prices and expand supply, and promoting equitable access in more than 100 countries.

This recognition reflects the dedication of our partners and teams, and the strength of our access to innovation approach in an increasingly challenging financing environment. As a founding supporter since 2006, the United Kingdom remains a key partner in advancing our work. Together, we will continue expanding equitable access to innovation across HIV, tuberculosis, malaria, maternal and child health and pandemic preparedness, ensuring that the latest health solutions reach the people who need them most.

Learn more: https://unitaid.org/news-blog/united-kingdom-review-reaffirms-unitaids-impact-as-a-critical-enabler-of-global-health-awards-a-plus-rating/

19/02/2026

L’hépatite C peut être guérie, mais des millions restent sans diagnostic ni traitement, surtout dans les pays à revenu faible ou intermédiaire.

Découvrez comment Unitaid agit pour mettre fin à cette menace :https://unitaid.org/uploads/Hepatitis-C_FR.pdf

19/02/2026

Strong health systems are key for pandemic preparedness. Unitaid’s investments in medical oxygen ensure hospitals in low-income areas can provide life-saving care, especially for women and children.

Learn more:https://unitaid.org/assets/Pandemic-Prevention-Preparedness-and-Response.pdf

19/02/2026

In hospitals across East and Southern Africa, lack of reliable medical oxygen turns treatable illnesses into tragedies. Unitaid and partners are working to change this by building sustainable oxygen supply systems where they’re needed most.

18/02/2026

Preventable maternal and newborn deaths are often the result of system failures rather than a lack of medicines. Our new report outlines how countries and partners can strengthen product security and deliver impact at scale.

Learn more:

New report highlights innovative solutions to strengthen access to quality life-saving maternal and newborn health products

18/02/2026

Innovation isn’t always high-tech, it’s about smarter, more people-centered solutions. From portable TB screening to long-acting HIV prevention, Unitaid is backing 5 breakthroughs that bring care closer to those who need it most.

Find out more: https://unitaid.org/news-blog/5-innovations-to-watch/

17/02/2026

Alors que notre Directeur exécutif se prépare à prendre sa retraite plus t**d cette année, Unitaid entre dans un moment important de transition. Depuis 20 ans, Unitaid démontre que l’innovation, à elle seule, ne suffit pas. Les progrès résultent d’actions délibérées visant à garantir que les outils de santé soient abordables, accessibles et adaptés aux réalités de la vie des populations, en particulier dans les pays à revenu faible et intermédiaire.

À un moment où l’incertitude et les pressions financières s’accentuent dans le domaine de la santé mondiale, le rôle catalytique d’Unitaid est plus crucial que jamais. En agissant comme éclaireur, investisseur et acteur d’influence, nous aidons les pays et les partenaires à obtenir de meilleurs résultats avec des ressources limitées, à renforcer les soins de santé primaires et à accélérer l’accès durable à des innovations vitales dans les domaines du VIH, de la tuberculose, du paludisme, de la santé des femmes et des enfants, ainsi que dans des priorités émergentes telles que l’accès à l’oxygène et la production régionale.

Nous recrutons aujourd’hui notre prochain Directeur exécutif afin de conduire Unitaid dans son nouveau chapitre. Il s’agit d’une occasion unique pour un dirigeant expérimenté, guidé par des valeurs fortes, de façonner l’avenir de l’accès équitable à l’innovation en santé et de représenter Unitaid aux plus hauts niveaux mondiaux.

Pour en savoir plus et postuler :
https://careers.who.int/careersection/ex/jobdetail.ftl?job=2504426&tz=GMT%2B01%3A00&tzname=Europe%2FBerlin

17/02/2026

Cervical cancer is preventable and curable, yet 90 percent of cases and deaths occur in low- and middle-income countries. Our new funding opportunity aims to accelerate secondary prevention and save lives.

Apply by 9 April 2026.

Find out more:

New report highlights innovative solutions to strengthen access to quality life-saving maternal and newborn health products